Explore Comprehensive Drug Information from A to Z and the Latest Health News: Your Guide to Safe Health at Your Fingertips

Detailed and accurate information is provided on over 24,000 prescription and over-the-counter medicines for both consumers and healthcare professionals.

Popular drug searches

Latest Health News

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

Bristol Myers Squibb (NYSE BMY) today announced positive interim Phase 3 results from the SUCCESSOR-2 study (NCT05552976). In the trial, oral mezigdomide in com

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

Novo Nordisk Expands U.S. Patient Access to FDA-Approved Semaglutide Medicines Through Hims & Hers in Response to a Shift in Their U.S. GLP-1 Business Model

Plainsboro, NJ, US and Bagsv rd, Denmark, 09 March 2026 Novo Nordisk today announced it has reached an agreement with telehealth company Hims Hers that will tak

Novo Nordisk Expands U.S. Patient Access to FDA-Approved Semaglutide Medicines Through Hims & Hers in Response to a Shift in Their U.S. GLP-1 Business Model

Ipsen Voluntarily Withdraws Tazverik (tazemetostat) in Follicular Lymphoma and Epithelioid Sarcoma

PARIS, FRANCE, 09 March 2026 Ipsen (Euronext IPN ADR IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from a

Ipsen Voluntarily Withdraws Tazverik (tazemetostat) in Follicular Lymphoma and Epithelioid Sarcoma

AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

AbbVie (NYSE ABBV) today announced positive topline results1 from the multiple ascending dose (MAD) part of its Phase 1 study evaluating the safety, tolerabilit

AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

Annual Sunscreen Protection Can Cost as Little as $40 per Year

Using sunscreen can cost as little as 40 a year or as much as 1,400 a year, according to a study published online Feb. 18 in JAMA Dermatology.Maya Mundada, from

Annual Sunscreen Protection Can Cost as Little as $40 per Year
Read more latest health news

Living Healthy Tips

9 Best Foods to Try

Did you eat your seaweed today? DrugsLib tells why it’s one of the lesser-known health-boosting foods.

9 Best Foods to Try

The dentist says it’s time to have your wisdom teeth removed. What should you expect?

Anxiety in Teens: What to Know

While all teens feel anxiety from time to time, some feel it more than others. DrugsLib explains how anxiety can be treated.

Anxiety in Teens: What to Know

DrugsLib offers strength training and weight lifting tips for teens.

Wondering if you might be pregnant? Look out for these early symptoms that could mean you're expecting. Learn more about the signs of pregnancy in this guide.

DrugsLib explains kennel cough, including how it is transmitted to dogs, symptoms, causes, treatments, and prevention.

Craft a healthy grocery list quickly! Find out how to build a budget-friendly grocery list that fills your meals with nutritious options.

What are some developmental milestones your child should have reached by 18 months?

Prostatitis, an inflamed and painful prostate gland, is a common condition. Learn some of the causes, symptoms and treatment of this condition.

My TK2d Diagnosis Story

A TK2d diagnosis is scary, but life with TK2d is doable thanks to the new treatment Kygevvi. Here's what one family wants you to know about this condition.

My TK2d Diagnosis Story
Read more living healthy tips

Popular Keywords